Construction Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.

Press releases published on September 2, 2026

Major Drilling Announces Record Quarterly Revenue for Its First Quarter 2027
Zoom Appoints Former Oracle CFO Jeff Epstein to Board of Directors; Jonathan Chadwick to Retire
SONORO GOLD ANNOUNCES MANAGEMENT APPOINTMENTS
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Byrna Appoints Matt McBrady to Board of Directors
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Supernus Pharmaceuticals to Participate in September Investor Conferences
Survey: 80% of British Columbians say financial institutions should advocate for consumers' financial well-being
Vireo Growth Announces Conference Attendance for September 2026
Methode Electronics, Inc. Reports Fiscal 2027 First Quarter Financial Results
Coverall of Gainesville Celebrates 40th 5-star Review and Perfect 5-Star Google Rating, Reinforcing Role as Best Commercial Cleaning Service in Gainesville, FL
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
Matrix Announces Award for Front-End Engineering and Design on America First Refining Storage Tank Farm in Brownsville, Texas
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
Nyxoah Annonce que l'Étude Pivot Américaine ACCCESS Atteint ses Critères Principaux de Sécurité et d'Efficacité chez les Patients Présentant un Collapsus Concentrique Complet
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Construction Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.